RxDoctor Payments Data

Renee Wheeler, DO

Family Medicine · Atlanta, GANPI 1285746867

Payments from drug & device makers

$530in general payments, 2019–2025

Across 30 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$191
  • GSK$161
  • Johnson & Johnson$47
  • Bayer$46
  • Merck$35
  • Lilly USA, LLC$33
  • plus $18 from 1 others

What the payments were for

  • Food & beverage$530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer11$191
GSK9$161
Johnson & Johnson3$47
Bayer2$46
Merck2$35
Lilly USA, LLC2$33
Neotract Inc.1$18

How this compares

$530 in reported general payments places this provider in the 45th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$11,835
Medicare patients
56
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol84$101,560
OzempicSemaglutide73$90,825
EliquisApixaban97$74,523
JanuviaSitagliptin Phosphate55$72,318
TrulicityDulaglutide58$67,492
JardianceEmpagliflozin35$48,842
XareltoRivaroxaban30$25,460
EntrestoSacubitril/Valsartan14$16,270
CreonLipase/Protease/Amylase13$15,935
Tresiba Flextouch U-100Insulin Degludec18$15,700
Atrovent HfaIpratropium Bromide25$14,163
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$12,664
Spiriva RespimatTiotropium Bromide17$11,701
Fluticasone-SalmeterolFluticasone Propion/Salmeterol56$10,865
Albuterol Sulfate HfaAlbuterol Sulfate303$10,179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$191$74,52397 claims
MerckJanuvia$35$72,31855 claims
Lilly USA, LLCTrulicity$33$67,49258 claims
Johnson & JohnsonXarelto$47$25,46030 claims
GSKTrelegy Ellipta$161$12,66416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →